Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway
Endocrine Journal · 2024
DOI: 10.1507/endocrj.ej24-0122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Journal, 2024. Verfasst von Wenting Yu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control, Red Flag Hospital Affiliated to Mudanjiang Medical College, Heilongjiang 157011, China. Hauptthemen laut MEDLINE: Glucosides, Apoptosis, Human Umbilical Vein Endothelial Cells, Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Control, Red Flag Hospital Affiliated to Mudanjiang Medical College, Heilongjiang 157011, China.
- The Third Department of Ophthalmology, Mudanjiang Medical College Affiliated Hongqi Hospital First Branch, Heilongjiang 157099, China.
Zitieren
APA
Yu, W., & Jiang, H. (2024). Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway. Endocrine Journal. https://doi.org/10.1507/endocrj.ej24-0122
Vancouver
Yu W, Jiang H. Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway. Endocrine Journal. 2024. doi:10.1507/endocrj.ej24-0122
BibTeX
@article{Yu2024,
author = {Yu, Wenting and Jiang, Hongchun},
title = {Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway},
journal = {Endocrine Journal},
year = {2024},
doi = {10.1507/endocrj.ej24-0122}
}
EUVIMED